Anna Eshoo

In May 2023, Anna Eshoo furthered her advocacy for data privacy and consumer protection in the tech industry by supporting legislation aimed at strengthening privacy laws to protect consumer data. This ongoing legislative initiative sought to address growing concerns regarding data breaches and lack of transparency in how consumer data is used by companies. Eshoo's efforts underscored her commitment to advancing legislation that responds to technological advancements, reinforcing her role in tech policy advocacy as a representative from Silicon Valley.

Anna Eshoo voted for the Inflation Reduction Act on August 12, 2022. This legislation aimed to combat inflation by reducing the federal budget deficit, lowering prescription drug costs for seniors, and investing in carbon emission reduction. Eshoo's vote aligned with her priorities to address climate change, healthcare reform, and economic stability. The Act marked significant advancements in climate policy and economic measures, showcasing Eshoo's continued advocacy for forward-thinking economic and environmental reforms.

On November 5, 2021, Anna Eshoo voted in favor of the Infrastructure Investment and Jobs Act, a comprehensive legislation investing in America's infrastructure including roads, bridges, rail, broadband, ports, and airports. The act, also known as the Bipartisan Infrastructure Bill, was aimed at long-term investments to improve America's infrastructure, create jobs, and enhance connectivity. Eshoo's support for the bill was consistent with her policy goals of modernizing infrastructure and supporting economic development.

Anna Eshoo introduced the Protecting Seniors Through Immunization Act on February 25, 2021. This proposed legislation aimed to eliminate cost-sharing for vaccines under Medicare Part D, thus encouraging more seniors to receive vaccinations. Eshoo's work emphasized the importance of preventive care and elder health, responding to the heightened awareness of vaccines' role in public health amidst the COVID-19 pandemic. Her legislative efforts reflected her ongoing commitment to improving the healthcare system for seniors.

On March 27, 2020, Congresswoman Anna Eshoo supported the passage of a $2 trillion COVID-19 relief package known as the CARES Act. This significant legislative effort was designed to provide emergency assistance and health care response for individuals, families, and businesses affected by the COVID-19 pandemic. Eshoo's vote was part of a broad congressional effort to mitigate the economic impact of the pandemic and to support public health initiatives, illustrating her dedication to her constituents during a global crisis.

In May 2018, Anna Eshoo was a vocal advocate for restoring net neutrality protections. Following the FCC's decision to repeal net neutrality rules, Eshoo supported legislative efforts to overturn the FCC's actions and preserve an open internet. Her work in this area was particularly focused on ensuring that internet service providers could not engage in practices that were detrimental to consumers and small businesses. Eshoo's advocacy reaffirmed her commitment to consumer rights and technological innovation policy efforts.

Anna Eshoo played an integral role in the development and passage of the Medicare Part D Patient Safety and Drug Abuse Prevention Act, passed on July 10, 2015. The legislation aimed to combat prescription drug abuse and fraud in Medicare, introducing new programs to monitor prescription drug use among beneficiaries. Eshoo's advocacy for patient safety and her efforts in curbing opioid abuse were well-reflected in her steadfast support and strategic legislative actions to address these critical health issues.

On May 21, 2014, Congresswoman Anna Eshoo co-sponsored the bipartisan 21st Century Cures Act, aimed at accelerating the discovery, development, and delivery of new treatments and cures for diseases. This landmark legislation sought to promote innovation in the biomedical research community and provided significant funding and support to the National Institutes of Health (NIH) to lead the global fight against diseases. Eshoo's leadership in science and technology issues continued through this legislative effort.

In September 2000, Anna Eshoo played a key role in addressing the high cost of prescription drugs in the United States. As a member of the House Subcommittee on Health, she worked on legislation aimed at making medications more affordable for seniors and other vulnerable populations. Eshoo's efforts contributed to the ongoing national dialogue about healthcare reform and affordability, highlighting her commitment to addressing constituent concerns in her district.

Anna Eshoo was elected to the United States House of Representatives in November 1992 and assumed office on January 3, 1993. Representing California's 14th congressional district, she succeeded retiring incumbent Tom Campbell. Eshoo, a member of the Democratic Party, has since been involved in various legislative efforts focused on health care, consumer protection, and technology, reflecting the interests of her Silicon Valley constituency.